Modernized Software for Calculation and Optimization of Absorbed Dose Distribution in a Homogeneous Medium during Radiation Therapy with Fast Neutrons
- Autores: Vertinskiy A.V.1,2, Selikhova E.A.2, Sukhikh E.S.2,3, Velikaya V.V.3, Gribova O.V.3, Starceva Z.A.3
-
Afiliações:
- Tomsk Regional Oncology Center
- National Research Tomsk Polytechnic University
- Tomsk National Research Medical Center
- Edição: Volume 70, Nº 1 (2025)
- Páginas: 67-73
- Seção: Radiation Therapy
- URL: https://journals.rcsi.science/1024-6177/article/view/361463
- DOI: https://doi.org/10.33266/1024-6177-2025-70-1-67-73
- ID: 361463
Citar
Texto integral
Resumo
Purpose: To modernize software for calculation and optimization of isoeffective and absorbed dose distributions in a homogeneous media when planning fast neutron therapy for malignant tumours.
Material and Methods: The updated absorbed dose calculation system was applied to patients with two localisations, breast cancer (BC) and head and neck cancer (HNC). The study included data from 12 patients, of which 7 were patients with primary locally advanced breast cancer and 5 patients with head and neck cancer. In patients with BC, comprehensive treatment was performed. Patients with malignant tumours of the head and neck region underwent neutron and neutron-photon radiation therapy both in terms of combined treatment and as an independent type of treatment. Breast cancer was irradiated in fractionation mode with 4 fractions of 1.6 Gy each. Field docking was used. Patients diagnosed with head and neck cancer were irradiated in the mode of 3 fractions with a single dose of 2.4 Gy with the duration of the full course of treatment of 8 days. Irradiation took place on the therapeutic channel of the U-120 cyclotron located at Tomsk Polytechnic University.
Results: The planning results showed that the dose to the skin in the irradiation zone was 3.190 Gy and 3.143 Gy for beams 1 and 2, respectively. In the tumour centre, the dose was 3.253 Gy (isoeffective dose 7.980 isoGy). For critical sites (heart), the maximum doses ranged from 0.507 Gy to 1.943 Gy. ). The duration of exposure from each beam was 4 minutes and 26 seconds. For five patients with cancer in the head and neck region, planning was performed using 2 fields separated by an angle of 90 degrees (irradiation angles of 45 and 315 degrees). The fractionation regime included: 3 sessions with tumour dose 2.4 Gy, total dose 7.2 Gy per treatment course. The full course of neutron therapy was carried out in 8 days. TDF in the tumour zone was 55.4 units, with the maximum permissible value of 130 units. As a result, the dose to the skin was from 5.8 to 7.5 Gy. The dose to the tumour centre ranged from 7.1 to 7.23 Gy (taking into account RBE = 2.686 isoeffective dose ranged from 37.9 to 38.4 isoGy). Total treatment time per fraction was from 12.3 to 13.5 minutes.
Sobre autores
A. Vertinskiy
Tomsk Regional Oncology Center; National Research Tomsk Polytechnic University
Email: avvertinskiy@tpu.ru
Tomsk, Russia
E. Selikhova
National Research Tomsk Polytechnic University
Email: avvertinskiy@tpu.ru
Tomsk, Russia
E. Sukhikh
National Research Tomsk Polytechnic University; Tomsk National Research Medical Center
Email: avvertinskiy@tpu.ru
Tomsk, Russia
V. Velikaya
Tomsk National Research Medical Center
Email: avvertinskiy@tpu.ru
Tomsk, Russia
O. Gribova
Tomsk National Research Medical Center
Email: avvertinskiy@tpu.ru
Tomsk, Russia
Zh. Starceva
Tomsk National Research Medical Center
Email: avvertinskiy@tpu.ru
Tomsk, Russia
Bibliografia
- Седов В.П., Лисин В.А. Модель ВДФ для дистанционной терапии злокачественных опухолей быстрыми нейтронами // Мед. радиология. 1988. Т.33. №9. С. 9-12.
- Лисин В.А. Линейно-квадратичная модель в планировании нейтронной терапии на циклотроне У-120 // Медицинская радиология и радиационная безопасность. 2018. Т.63. №5. С. 41-47.
- Лисин В.А. Дозиметрическое компьютерное планирование гамманейтронной терапии злокачественных опухолей с использованием циклотрона У-120 // Медицинская радиология и радиационная безопасность. 1994. Т.39. № 5.С. 53-57.
- Чойнзонов Е.Л., Лисин В.А., Грибова О.В., Новиков В.А., Старцева Ж.А. Нейтронная терапия злокачественных новообразований головы и шеи: Монография. М.: Российская академия наук, 2021. 328 с.
- Старцева Ж.А., Грибова О.В., Великая В.В., Сухих Е.С., Лисин В.А., Новиков В.А. Дистанционная нейтронная терапия в Томске: 40 лет на службе онкологии // Сибирский онкологический журнал. 2024. Т.23. №1. С. 98-108.
- Великая В.В., Старцева Ж.А., Гольдберг В.Е., Попова Н.О. Десятилетние результаты комплексного лечения больных первичным местнораспространенным раком молочной железы // Медицинская радиология и радиационная безопасность. 2023. Т.68. №5. С. 71-76.
- Musabaeva L.I., Startseva Zh.A., Gribova O.V., Velikaya V.V., Lisin V.A. Novel Technologies and Theoretical Models in Radiation Therapy of Cancer Patients Using 6.3 MeV Fast Neutrons Produced by U-120 Cyclotron // Proceedings of the International Conference on Physics of Cancer: Interdisciplinary Problems and Clinical Applications, 2016 22–25 March. Russia, Tomsk, 2016.
- Мусабаева Л.И., Чойнзонов Е.Л., Грибова О.В., Старцева Ж.А., Великая В.В., Лисин В.А. Нейтронная терапия в лечении радиорезистентных злокачественных новообразований // Сибирский онкологический журнал. 2016. Т.15. №3. С. 67-71.
- Грибова О.В., Мусабаева Л.И., Чойнзонов Е.Л., Мухамедов М.Р. Клиническое течение рака щитовидной железы после комбинированного лечения с применением быстрых нейтронов у больных с высоким риском рецидива // Вестник оториноларингологии. 2012. №5. С. 91-92.
- Ellis F. Dose, time and fractionation: A clinical hypothesis // Clin. Radiol. 1969. Vol. 20. P. 1‒7.
Arquivos suplementares
